70 related articles for article (PubMed ID: 16774755)
21. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
Carević V; Rumboldt M; Rumboldt Z;
Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
[TBL] [Abstract][Full Text] [Related]
22. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study.
Empana JP; Ducimetière P; Arveiler D; Ferrières J; Evans A; Ruidavets JB; Haas B; Yarnell J; Bingham A; Amouyel P; Dallongeville J;
Eur Heart J; 2003 Nov; 24(21):1903-11. PubMed ID: 14585248
[TBL] [Abstract][Full Text] [Related]
23. Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study.
Scarabin PY; Arveiler D; Amouyel P; Dos Santos C; Evans A; Luc G; Ferrières J; Juhan-Vague I;
Atherosclerosis; 2003 Jan; 166(1):103-9. PubMed ID: 12482556
[TBL] [Abstract][Full Text] [Related]
24. Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study.
Ducimetière P; Ruidavets JB; Montaye M; Haas B; Yarnell J;
Int J Epidemiol; 2001 Oct; 30(5):1057-62. PubMed ID: 11689522
[TBL] [Abstract][Full Text] [Related]
25. Gender-related differences in the relationship between plasma homocysteine, anthropometric and conventional biochemical coronary heart disease risk factors in middle-aged Indians.
Pitla S; Nagalla B
Ann Nutr Metab; 2009; 54(1):1-6. PubMed ID: 19194102
[TBL] [Abstract][Full Text] [Related]
26. Elevated plasma homocysteine level is associated with ischemic stroke in Chinese hypertensive patients.
Wang CY; Chen ZW; Zhang T; Liu J; Chen SH; Liu SY; Han LY; Hui ZH; Chen YM
Eur J Intern Med; 2014 Jul; 25(6):538-44. PubMed ID: 24824758
[TBL] [Abstract][Full Text] [Related]
27. Serum total homocysteine and coronary heart disease.
Arnesen E; Refsum H; Bønaa KH; Ueland PM; Førde OH; Nordrehaug JE
Int J Epidemiol; 1995 Aug; 24(4):704-9. PubMed ID: 8550266
[TBL] [Abstract][Full Text] [Related]
28. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis.
Humphrey LL; Fu R; Rogers K; Freeman M; Helfand M
Mayo Clin Proc; 2008 Nov; 83(11):1203-12. PubMed ID: 18990318
[TBL] [Abstract][Full Text] [Related]
29. Serum homocysteine as a risk factor for coronary heart disease.
Naureen A; Munazza B; Shaheen R; Khan SA; Fatima F
J Ayub Med Coll Abbottabad; 2012; 24(1):59-62. PubMed ID: 23855097
[TBL] [Abstract][Full Text] [Related]
30. Serum homocysteine and folate but not vitamin B12 are predictors of CHD mortality in older adults.
Gopinath B; Flood VM; Rochtchina E; Thiagalingam A; Mitchell P
Eur J Prev Cardiol; 2012 Dec; 19(6):1420-9. PubMed ID: 21960652
[TBL] [Abstract][Full Text] [Related]
31. Human plasma complement C3 is independently associated with coronary heart disease, but only in heavy smokers (the CODAM study).
van Greevenbroek MM; Jacobs M; van der Kallen CJ; Blaak EE; Jansen EH; Schalkwijk CG; Feskens EJ; Stehouwer CD
Int J Cardiol; 2012 Jan; 154(2):158-62. PubMed ID: 20926148
[TBL] [Abstract][Full Text] [Related]
32. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
Shai I; Rimm EB; Hankinson SE; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J
Circulation; 2004 Nov; 110(18):2824-30. PubMed ID: 15492318
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
Blankenberg S; Luc G; Ducimetière P; Arveiler D; Ferrières J; Amouyel P; Evans A; Cambien F; Tiret L;
Circulation; 2003 Nov; 108(20):2453-9. PubMed ID: 14581397
[TBL] [Abstract][Full Text] [Related]
34. Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up.
Fallon UB; Ben-Shlomo Y; Elwood P; Ubbink JB; Smith GD
Heart; 2001 Feb; 85(2):153-8. PubMed ID: 11156664
[TBL] [Abstract][Full Text] [Related]
35. Homocysteine and cardiovascular disease: a 17-year follow-up study in Busselton.
O'Leary CM; Knuiman MW; Divitini ML
Eur J Cardiovasc Prev Rehabil; 2004 Aug; 11(4):350-1. PubMed ID: 15292770
[TBL] [Abstract][Full Text] [Related]
36. New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokers.
O'Callaghan PA; Fitzgerald A; Fogarty J; Gaffney P; Hanbidge M; Boran G; Enright H; Murphy J; McCarthy B; Graham IM
Eur J Cardiovasc Prev Rehabil; 2005 Dec; 12(6):542-7. PubMed ID: 16319543
[TBL] [Abstract][Full Text] [Related]
37. Family history, longevity, and risk of coronary heart disease: the PRIME Study.
Yarnell J; Yu S; Patterson C; Cambien F; Arveiler D; Amouyel P; Ferrières J; Luc G; Evans A; Ducimetière P
Int J Epidemiol; 2003 Feb; 32(1):71-7. PubMed ID: 12690013
[TBL] [Abstract][Full Text] [Related]
38. Association of TGFB1 rs1800469 and BCMO1 rs6564851 with coronary heart disease and IL1B rs16944 with all-cause mortality in men from the Northern Ireland PRIME study.
Mooney RE; Linden GJ; Winning L; Linden K; Kee F; McKeown PP; Woodside JV; Patterson CC; McKay GJ
PLoS One; 2022; 17(8):e0273333. PubMed ID: 35994463
[TBL] [Abstract][Full Text] [Related]
39. The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective Epidemiological Study of Myocardial Infarction.
Yarnell JW
QJM; 1998 Oct; 91(10):667-76. PubMed ID: 10024924
[TBL] [Abstract][Full Text] [Related]
40. Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease?
Knekt P; Reunanen A; Alfthan G; Heliövaara M; Rissanen H; Marniemi J; Aromaa A
Arch Intern Med; 2001 Jul; 161(13):1589-94. PubMed ID: 11434790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
